OFI Advisors’s Medicines Co MDCO Stock Holding History

OFI Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$276K	Sell	7,282 -6,434	-47%	-$226K	0.02%	1038
2015 Q2	$392K	Buy	13,716 +701	+5%	+$19.5K	0.02%	898
2015 Q1	$365K	Sell	13,015 -366	-3%	-$10.3K	0.02%	931
2014 Q4	$370K	Buy	13,381 +362	+3%	+$8.97K	0.02%	880
2014 Q3	$291K	Buy	13,019 +1,177	+10%	+$29.9K	0.02%	953
2014 Q2	$344K	Buy	11,842 +1,847	+18%	+$49.3K	0.02%	871
2014 Q1	$284K	Buy	9,995 +2,756	+38%	+$91.2K	0.02%	927
2013 Q4	$280K	Buy	7,239 +967	+15%	+$34.6K	0.02%	905
2013 Q3	$210K	Buy	6,272 +1,643	+35%	+$52.3K	0.02%	947
2013 Q2	$142K	Buy	+4,629	New	+$155K	0.01%	1078

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OFI Advisors's MDCO Position: Q3 2015 in Review

OFI Advisors reduced its Medicines Co (MDCO) stake by 47% in Q3 2015, selling an estimated $226K and leaving 7,282 shares worth $276K. The position accounts for 0.02% of the portfolio, ranked #1038.

OFI Advisors first reported a position in MDCO in Q2 2013 and has held it in 10 quarters since. The position peaked at $392K in Q2 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

OFI Advisors held 7,282 shares of Medicines Co worth $276K as of Q3 2015.
OFI Advisors sold 6,434 Medicines Co shares in Q3 2015, an estimated $226K.
Medicines Co made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #1038 holding.
OFI Advisors first reported a position in Medicines Co in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Medicines Co position peaked at $392K in Q2 2015.
183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.